Flow Cytometry Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Instruments, Reagents & Consumables, Software, Accessories, Services), By Technology (Cell-based, and Bead-based), By Application (Research, Industrial, and Clinical), By End-use (Commercial Organizations, Hospitals, Academic Institutes, and Clinical Testing Labs)
Report Code: TIPHE100000978
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
Flow cytometry helps in analyzing the expression of cell surface and intracellular molecules. It is a laser, or an impedance-based technology used in cell counting, detecting biomarker, cell sorting, and protein engineering by suspending the cell in a stream of fluid and then passing it through a detection apparatus. It is the ideal tool to identify, characterize, and isolate stem and progenitor cells for research and potential clinical use.
Flow cytometry is commonly used for the diagnosis of cancer and immunodeficiency. The increasing prevalence of these diseases is one of the factors expected to drive the market for flow cytometry over the forecast period. According to WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Each year, approximately 400 000 children develop cancer. The most common cancers vary between countries. In addition, due to rising healthcare expenditure in developed countries and improved healthcare facilities, the biotechnology sector is predicted to increase significantly throughout the coming years. The market is likely to be driven by an increase in government funding for clinical studies relevant to in vitro molecular diagnostics, as it plays a critical role in the development of new products. Significant market expansion has resulted from increased investments in notable biotech and biopharma companies. In comparison to the United States, Chinese investors are increasingly focusing on European biotech enterprises. For example, in 2019, they invested over USD 400 million in European companies, a significant increase over 2017, when they invested less than USD 100 million. In 2019, out of USD 14.92 billion invested in various life science companies, approximately 64.6% of it has been used by the biotechnology sector.
Moreover, a major factor driving the growth of the flow cytometry market is the increasing use of flow cytometry in clinical research. For instance, Becton, Dickinson, and Company released the revamped digital marketplace for flow cytometry in July 2021 to provide consumers and their procurement teams with a better online purchase experience. The new BD Biosciences marketplace includes a full range of BD's research, clinical, and single-cell multi-omic products, making it a one-stop shop for flow cytometry experts. BD Life Sciences-Biosciences has inaugurated its second Center of Excellence (CoE) in flow cytometry for clinical research in India in October 2021, in conjunction with Christian Medical College, Vellore. As a result of these developments, demand for flow cytometry is increasing, propelling the market forward.
MARKET TRENDS/MARKET SCENARIO
Several companies in the Flow Cytometry market are in the process of continuously developing innovative products.
For instance, in June 2021, Thermo Fisher Scientific, Inc. (US) launched Attune CytPix Flow Cytometer, a benchtop instrument that helps researchers working in QA/QC or cell therapy applications to gather additional information about cells and the sample quality while running flow cytometry experiments without sacrificing speed or simplicity.
MARKET SCOPE AND REPORT FEATURES
Our report on "Global Flow Cytometry Market Analysis to 2028" encapsulate a detailed market analysis on key segments such as product, technology, applications and end use of Flow Cytometry Market, and a deep dive statistical and qualitative analysis by geography covering five key regions and several countries. As a part of qualitative analysis report offers evaluation of key market dynamics such prevailing market driver, key challenges and opportunities that pave the path for future developments. Further, our analysis on the key competition provide a strategic view point on the market initiatives, SWOT analysis, and highlights on the products and service developments of the players.
MARKET SEGMENTATION Global Flow Cytometry Market – By Product
REGIONAL INSIGHTS The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South America. The Flow Cytometry market by each region is later sub segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Flow Cytometry market in these regions.
The report covers key developments in the Flow Cytometry market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Flow Cytometry market are anticipated to lucrative growth opportunities in the future with the rising demand in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Flow Cytometry market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Becton Dickinson and Company
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Apogee Flow Systems Ltd.
Thermo Fisher Scientific, Inc.
Our report on Flow Cytometry Market cover following key parameters:
Comprehensive market analysis at global, regional and country level
Detailed PEST (Political, Economic, Social and Technological) factors impacting the market across key geographic regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America
Market dynamics (drivers, restraints, opportunities, and future trends) and impact analysis of drivers and restraints at short-term, mid-term and long-term
Market size and forecasts in terms of revenue; 2020 (historic), 2021 (base year), 2022 – 28 (forecast period)
In-depth market segmentation and deep dive regional and country level analysis of 18+ countries across 5 key regions
Key company profiles and industry landscape to provide latest market initiatives and competitive landscape
Impact of COVID`19 pandemic on ecosystem and the market
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies
1. Thermo Fisher Scientific, Inc. 2. Merck KGaA 3. Novozymes 4. Agilent Technologies 5. Amyris 6. Genscript 7. Integrated DNA Technologies, Inc. 8. Twist Bioscience 9. New England Biolabs (NEB) 10. Synthetic Genomics, Inc. 11. Sony Biotechnology, Inc. 12. Stratedigm, Inc.